DENVER BUSINESS JOURNAL – Cheaper generic biotech drugs loom as ‘biosimilars’ law advances in Colorado Legislature

The U.S. Food & Drug Administration approved the first generic version of a biotech drug for domestic sale Friday, hours after Colorado state legislators wrestled with how to let pharmacists handle cheaper biotech drug knockoffs.

Colorado is among several states considering proposals to let pharmacists substitute FDA-approved biotech generics — known as “biosimilars” — for name-brand drugs that are prescribed by a doctor.

Click Here to read more